Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
Gender differences in pressure-natriuresis and renal autoregulation: role of the Angiotensin type 2 receptorLucinda M Hilliard, Mehdi Nematbakhsh, Michelle M Kett, et al.
Journal of Molecular Recognition : JMR|June 16, 2010
β-Amino acid substitution to investigate the recognition of angiotensin II (AngII) by angiotensin converting enzyme 2 (ACE2)Daniel Clayton, Iresha Hanchapola, Nicholas Hausler, et al.
International Journal of Molecular Sciences|November 26, 2022
The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed MiceYan Wang, Jonathan Yodgee, Mark Del Borgo, et al.
ACS Pharmacology & Translational Science|April 19, 2024
Hi1a Improves Sensorimotor Deficit following Endothelin-1-Induced Stroke in Rats but Does Not Improve Functional Outcomes following Filament-Induced Stroke in MiceAdriana Knezic, Elena Budusan, Natalie J Saez, et al.
Pharmacological Reviews|September 30, 2022
The Angiotensin AT<sub>2</sub> Receptor: From a Binding Site to a Novel Therapeutic TargetU Muscha Steckelings, Robert E Widdop, Edward D Sturrock, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2023
The protective effects of a novel AT<sub>2</sub> receptor agonist, β-Pro<sup>7</sup>Ang III in ischemia-reperfusion kidney injuryTingfang Zhang, Yifang Li, Andrea F Wise, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 17, 2020
The anti-fibrotic actions of relaxin are mediated through AT<sub>2</sub> R-associated protein phosphatases via RXFP1-AT<sub>2</sub> R functional crosstalk in human cardiac myofibroblastsChao Wang, Anita A Pinar, Robert E Widdop, et al.
British Journal of Pharmacology|January 15, 2021
Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertensionYifang Li, Matthew Shen, Dorota Ferens, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Serelaxin and the AT<sub>2</sub> Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan CilexetilYan Wang, Lei Han, Matthew Shen, et al.
Experimental & Translational Stroke Medicine|August 28, 2012
Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivoSeyoung Lee, Vanessa H Brait, Thiruma V Arumugam, et al.
Pageof 12